Comparative safety of dipeptidyl peptidase‐4 inhibitors and sulfonylureas among frail older adults

Background Studies comparing dipeptidyl peptidase‐4 inhibitors (DPP4Is) to sulfonylureas (SUs) are unavailable for frail older adults, especially nursing home (NH) residents. We examined the effects of DPP4Is versus SUs on severe adverse glycemic events, cardiovascular events, and death among NH residents. Methods We conducted a national retrospective cohort study of long‐stay NH residents aged ≥65 years using 2008–2010 national US Minimum Data...